BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12013294)

  • 21. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
    Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
    Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracapsular spread of nodal metastasis as a prognostic factor in rectal cancer.
    Heide J; Krüll A; Berger J
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):773-8. PubMed ID: 14967433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New tumor-node-metastasis staging strategy for node-positive (stage III) rectal cancer: an analysis.
    Greene FL; Stewart AK; Norton HJ
    J Clin Oncol; 2004 May; 22(10):1778-84. PubMed ID: 14769855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative chemoradiation for rectal cancer causes prolonged pudendal nerve terminal motor latency.
    Lim JF; Tjandra JJ; Hiscock R; Chao MW; Gibbs P
    Dis Colon Rectum; 2006 Jan; 49(1):12-9. PubMed ID: 16292664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
    Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct.
    Hughes MA; Frassica DA; Yeo CJ; Riall TS; Lillemoe KD; Cameron JL; Donehower RC; Laheru DA; Hruban RH; Abrams RA
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):178-82. PubMed ID: 17276614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial.
    Bujko K; Michalski W; Kepka L; Nowacki MP; Nasierowska-Guttmejer A; Tokar P; Dymecki D; Pawlak M; Lesniak T; Richter P; Wojnar A; Chmielik E;
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):369-77. PubMed ID: 17118570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative radiotherapy for rectal adenocarcinoma: Which are strong prognostic factors?
    Chapet O; Romestaing P; Mornex F; Souquet JC; Favrel V; Ardiet JM; d'Hombres A; Gerard JP
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1371-7. PubMed ID: 15817339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introduction of preoperative radiotherapy in the treatment of operable rectal cancer in the Southwest region of the Netherlands.
    Vermaas M; Gosselink MP; Ferenschild FT; van den Aardweg E; Lont HE; Kemperman HW; van der Harst E; Tetteroo GW; Oostenbroek RJ; Dijkhuis CM; Eggermont AM; de Wilt JH
    Eur J Surg Oncol; 2007 Sep; 33(7):862-7. PubMed ID: 17257804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What factors affect lymph node yield in surgery for rectal cancer?
    Thorn CC; Woodcock NP; Scott N; Verbeke C; Scott SB; Ambrose NS
    Colorectal Dis; 2004 Sep; 6(5):356-61. PubMed ID: 15335370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
    Miller RC; Iott MJ; Corsini MM
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Single and multifactorial prognostic study of 400 operated rectal adenocarcinomas].
    Lasser P; Mankarios H; Elias D; Bognel C; Eschwege F; Wibault P; Kac J; Crespon B; Rougier P
    J Chir (Paris); 1993 Feb; 130(2):57-65. PubMed ID: 8514828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
    J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemo-radiotherapy versus radiotherapy alone in the pre-operative treatment of resectable rectal cancer.
    Goethals L; Haustermans K; Perneel C; Bussels B; D'Hoore A; Geboes K; Ectors N; Van Cutsem E; Van den Bogaert W; Penninckx F
    Eur J Surg Oncol; 2005 Nov; 31(9):969-76. PubMed ID: 15936170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
    Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR
    Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer.
    Peschaud F; Benoist S; Julié C; Beauchet A; Penna C; Rougier P; Nordlinger B
    Ann Surg; 2008 Dec; 248(6):1067-73. PubMed ID: 19092352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A short course of preoperative radiotherapy improves prognosis of operable rectal carcinoma: a case control study.
    Penopoulos V; Handolias M; Avgerinos A; Maris T; Ilias T; Issopoulos N; Christianopoulos G; Betsis D; Vrettou E; Kitis G; Pistevou K
    Hepatogastroenterology; 2008; 55(85):1280-7. PubMed ID: 18795673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of early postoperative morbidity among patients with rectal cancer treated with and without neoadjuvant chemoradiotherapy.
    Valenti V; Hernandez-Lizoain JL; Baixauli J; Pastor C; Aristu J; Diaz-Gonzalez J; Beunza JJ; Alvarez-Cienfuegos JA
    Ann Surg Oncol; 2007 May; 14(5):1744-51. PubMed ID: 17334851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging.
    Koh DM; Chau I; Tait D; Wotherspoon A; Cunningham D; Brown G
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):456-61. PubMed ID: 18164860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.